Forst T - Search Results

1

Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.

Steiner CA, Janez A, Jensterle M, Reisinger K, Forst T, Pfützner A. Steiner CA, et al. Among authors: forst t. J Diabetes Sci Technol. 2007 Mar;1(2):211-7. doi: 10.1177/193229680700100212. J Diabetes Sci Technol. 2007. PMID: 19888409 Free PMC article.

2

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.

Pfützner A, Küstner E, Forst T, Schulze-Schleppinghoff B, Trautmann ME, Haslbeck M, Schatz H, Beyer J. Pfützner A, et al. Among authors: forst t. Exp Clin Endocrinol Diabetes. 1996;104(1):25-30. doi: 10.1055/s-0029-1211418. Exp Clin Endocrinol Diabetes. 1996. PMID: 8750567 Clinical Trial.

3

Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.

Forst T, Kunt T, Pohlmann T, Goitom K, Engelbach M, Beyer J, Pfützner A. Forst T, et al. J Clin Invest. 1998 May 15;101(10):2036-41. doi: 10.1172/JCI2147. J Clin Invest. 1998. PMID: 9593759 Free PMC article. Clinical Trial.

4

New aspects on biological activity of C-peptide in IDDM patients.

Forst T, Kunt T, Pfützner A, Beyer J, Wahren J. Forst T, et al. Exp Clin Endocrinol Diabetes. 1998;106(4):270-6. doi: 10.1055/s-0029-1212190. Exp Clin Endocrinol Diabetes. 1998. PMID: 9792458 Review.

5

Response to Jungheim and Koschinsky.

Pfützner A, Forst T. Pfützner A, et al. Among authors: forst t. Diabetes Care. 2002 Mar;25(3):638-9; author reply 639-40. doi: 10.2337/diacare.25.3.638. Diabetes Care. 2002. PMID: 11874972 No abstract available.

6

Clinical and laboratory evaluation of specific chemiluminescence assays for intact and total proinsulin.

Pfützner A, Kunt T, Langenfeld M, Löbig M, Knesovic M, Forst T. Pfützner A, et al. Among authors: forst t. Clin Chem Lab Med. 2003 Sep;41(9):1234-8. doi: 10.1515/CCLM.2003.189. Clin Chem Lab Med. 2003. PMID: 14598875

7

Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.

Pfützner A, Langenfeld M, Kunt T, Löbig M, Forst T. Pfützner A, et al. Among authors: forst t. Clin Lab. 2003;49(11-12):571-6. Clin Lab. 2003. PMID: 14651328

8

Investigation on the accuracy of the blood glucose monitoring device Prestige IQ.

Larbig M, Forst T, Mondok A, Forst S, Pfützner A. Larbig M, et al. Among authors: forst s, forst t. Diabetes Nutr Metab. 2003 Aug;16(4):257-61. Diabetes Nutr Metab. 2003. PMID: 14768776 Clinical Trial.

9

Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.

Pfützner A, Kunt T, Hohberg C, Mondok A, Pahler S, Konrad T, Lübben G, Forst T. Pfützner A, et al. Among authors: forst t. Diabetes Care. 2004 Mar;27(3):682-7. doi: 10.2337/diacare.27.3.682. Diabetes Care. 2004. PMID: 14988285

10

[The diagnosis of an autonomic dysfunction of the lower limb as a major aspect of the neurological investigation and risk assessment of a diabetic foot syndrome].

Forst T, Pfützner A. Forst T, et al. MMW Fortschr Med. 2004 Jan 22;146(3-4):35-8. MMW Fortschr Med. 2004. PMID: 15035446 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters